chronic myeloid leukemia in chronic phase
“International Randomized Study of (2009), Interferon Vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib”, Blood 114, pp.
“International Randomized Study of ( 2009 ), Interferon Vs STI571 ( IRIS ) 8-year follow up : sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase ( CML-CP ) treated with imatinib”, Blood 114, pp .